Kessler Foundation: Clinical Trials

11 trials sponsored by Kessler Foundation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 unknown, 1 recruiting. 11 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 211Completed 7, Unknown 3, Recruiting 1
Phase 13Completed 2, Unknown 1

Follow Kessler Foundation: new trials by email

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Extracorporeal Shockwave Therapy as an Additional Treatment for Spasticity Secondary to Spinal Cord Injury
Focused extracorporeal shockwave therapy, Botulinum toxin, Sham - Spinal Cord Injury, Spasticity
Phase 2RecruitingKessler Foundation302026-09-212026-11-04
Ultrasound-Guided Injections for Meniscal Injuries in Active-Duty Military
Lipogems, Normal Saline - Tibial Meniscus Injuries, Knee Injuries
Phase 2CompletedKessler Foundation32019-07-012024-12-18
Ultrasound-Guided Treatments for Shoulder Pain in Wheelchair Users With Spinal Cord Injury
Lipogems, Dexamethasone - Spinal Cord Injuries, Tendinopathy
Phase 2UnknownKessler Foundation242019-06-142022-10-14
Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury
Oxybutynin Chloride IR, Mirabegron - Spinal Cord Injuries, Urinary Bladder, Neurogenic
Phase 2UnknownKessler Foundation622019-04-032019-12-17
TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males
Testosterone Gel applied by a pump, Stand Training, Electrical Stimulation - Spinal Cord Injury
Phase 1 / Phase 2UnknownKessler Foundation562017-03-152017-08-22
The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury
Midodrine Hydrochloride, Pyridostigmine Bromide, Mirabegron - Spinal Cord Injury, Autonomic Dysreflexia
Phase 2CompletedJames J. Peters Veterans Affairs Medical Center212016-12-012024-10-01
Improving Functioning in Persons With Chronic Pain Post-SCI Through Virtual Classroom Education
Education Program Type 1, Education Program Type 2 - Chronic Pain, Spinal Cord Injuries
Phase 1 / Phase 2CompletedKessler Foundation752015-03-012020-05-12
Testing the Effects of Methylphenidate on Multiple Sclerosis
Methelphenidate, Placebo - Fatigue in Multiple Sclerosis
Phase 2CompletedKessler Foundation362014-10-012025-09-02
Education Interventions for Self-Management of Pain Post-SCI: A Pilot Study
Education Program Type 1, Education Program Type 2 - Spinal Cord Injury, Chronic Pain
Phase 1 / Phase 2CompletedKessler Foundation292014-09-012020-05-12
Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord Injury
Dalfampridine, Placebo - Spinal Cord Injury
Phase 2CompletedKessler Foundation272012-06-012017-12-02
Preventing Pneumonia and Other Respiratory Problems in Persons With Spinal Cord Injury
Manual and mechanical assisted cough, Incentive spirometry - Spinal Cord Injury
Phase 2CompletedKessler Foundation1202007-06-012013-01-15

Conditions studied

Spinal Cord Injuries (9)  ·  Chronic Pain (2)  ·  Autonomic Dysreflexia (1)  ·  Cough (1)  ·  Disease (1)  ·  Knee Injuries (1)  ·  Multiple Sclerosis (1)  ·  Muscle Spasticity (1)  ·  Rotator Cuff Injuries (1)  ·  Shoulder Pain (1)  ·  Tendinopathy (1)  ·  Tibial Meniscus Injuries (1)  ·  Urinary Bladder, Neurogenic (1)

Interventions

mirabegron (2)  ·  4-Aminopyridine (1)  ·  Adrenal Cortex Hormones (1)  ·  Botulinum Toxins (1)  ·  Dexamethasone (1)  ·  Electric Stimulation (1)  ·  Midodrine (1)  ·  Pyridostigmine Bromide (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  oxybutynin (1)  ·  salicylhydroxamic acid (1)

Countries

United States (11)

Top investigators

Trevor A. Dyson-Hudson, M.D. (3)  ·  Jeanne M Zanca, PhD, MPT (2)  ·  Steven C. Kirshblum, M.D. (2)  ·  Gail F Forrest, PhD (1)  ·  Gail F. Forrest, Ph.D. (1)  ·  Jill M Wecht, Ed.D (1)  ·  John Bach, M.D. (1)  ·  Steven Kirshblum, M.D. (1)  ·  Todd A. Linsenmeyer, M.D. (1)

NIH funding

R21HD123083 (1)